Gopher Angels

Members evaluate deals through monthly screening sessions, relying on lead institutional VCs to set terms and lead diligence. Individual members then decide whether to participate in each deal through the group's pooled LLC. The network does not have a centralized investment committee with gating authority over member choices.

The group functions as a disciplined sidecar, co-investing alongside funds that lead rounds. Confirmed lead partners include Matchstick Ventures and Great North Labs, both Minnesota-based seed funds. Gopher Angels explicitly avoids competing for allocation leverage or board seats that the lead VC controls.

The group targets pre-seed, seed, and occasionally Series A rounds, writing checks between $50,000 and $250,000. Companies are typically pre-revenue or in early commercialization, and Gopher Angels requires a lead institutional investor to anchor the round before members commit.

The network has publicly stated it does not invest in real estate, retail franchises, or capital-intensive hardware manufacturing. It also avoids life sciences companies that require FDA clinical trial pathways, preferring digital health and medical-device adjacent plays where regulatory timelines are shorter and enterprise sales cycles map to member expertise.

Gopher Angels does not raise a blind pool or charge management fees on committed capital. Deals are syndicated on a per-company basis through an LLC, and each member decides whether to participate individually. This structure avoids the deployment-pressure incentives that traditional fund managers face and aligns member interests with opportunity-level diligence rather than portfolio theory.